During the past decade, Texas Cardiac Arrhythmia Research Foundation conducted 59 clinical trials. In the 10-year time frame, 59 clinical trials started and 41 clinical trials were completed, i.e. on average, 69.5% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 23 clinical trials were completed. i.e. 95.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Texas Cardiac Arrhythmia Research Foundation" #1 sponsor was "Abbott Medical Devices" with 18 trials, followed by "Boston Scientific Corporation" with 14 trials sponsored, "Medtronic Cardiac Rhythm and Heart Failure" with 12 trials sponsored, "Biosense Webster, Inc." with 8 trials sponsored and "Medtronic" with 8 trials sponsored. Other sponsors include 36 different institutions and companies that sponsored additional 36 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Texas Cardiac Arrhythmia Research Foundation" #1 collaborator was "Biosense Webster, Inc." with 3 trials as a collaborator, "Abbott Medical Devices" with 2 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "AtriCure, Inc." with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Texas Cardiac Arrhythmia Research Foundation" are "Atrial Fibrillation" (30 trials), "Heart Failure" (21 trials), "Paroxysmal Atrial Fibrillation" (10 trials), "Stroke" (8 trials) and "Ventricular Tachycardia" (7 trials). Many other conditions were trialed in "Texas Cardiac Arrhythmia Research Foundation" in a lesser frequency.

Most popular intervention types in "Texas Cardiac Arrhythmia Research Foundation" are "Device" (74 trials), "Drug" (18 trials), "Procedure" (9 trials), "Other" (7 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ablation" (3 trials), "Amiodarone" (3 trials), "LARIAT + PVI" (2 trials), "THERMOCOOL® SMARTTOUCH™ Catheter" (2 trials) and "Warfarin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Texas Cardiac Arrhythmia Research Foundation" are 99 trials for "All" genders.

Currently, there are NaN active trials in "Texas Cardiac Arrhythmia Research Foundation". undefined are not yet recruiting, 16 are recruiting, 16 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 53 completed trials in Texas Cardiac Arrhythmia Research Foundation, 2 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Texas Cardiac Arrhythmia Research Foundation, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 49 trials that are defined as “Not Applicable".